Lauren Gardner

But also at the same time, what is expected here is that

Probably about a dozen or so of these peptides will be moved to another category where legally it's okay for them to be made, but it's not like the FDA is going to be saying, don't worry, they're safe or safe enough, like it's no big deal.

It essentially is, it's like a regulatory purgatory.

Yeah.

The term of art in FDA parlance is enforcement discretion.

But even once that happens, it doesn't necessarily mean it's the end of the road because someone can petition the FDA to do something more formal on it, and then that would unleash a whole separate regulatory process that would take...

probably years to go through.

It does seem like there is some kind of

craze to be capitalized on here, but whether it's going to be, you know, one or two of these in particular, or just like a giant class of these substances that people are just going to be flocking to telehealth sites like HIMSS for, I think that's kind of the open question.

I think a lot of it's going to come down to how many

you know, quote-unquote legit actors start to step into this space.

And by that, I mean, in particular, the telehealth platforms like HIMSS, Rho, the ones that you see a lot of advertisements for on TV or online, how many of them get into this?

Because telehealth has also democratized access to things like GLP-1s in a way that has...

Fundamentally changed the industry, and I think that's how a lot of people would be accessing peptides as well, because you can easily access a provider and don't necessarily have to look up some wellness clinic in whatever area you happen to live in and see if there's someone who has any idea how BPC-157 works or might work for you.

Yeah, and these things aren't without risk, and I do think that can get lost in the conversation.

For instance, there was a case last summer of two women going to a wellness conference in Las Vegas, and they ended up getting really, really sick after they were injected with peptides there at this festival.

And just...

Earlier in March, Nevada regulators fined three people who played a role in offering peptides to attendees of this anti-aging conference.

So they're certainly not without risk.

And I think what is TBD is to what extent will people as like the pool of people